All In Biotech

Drug Trial Radar · NCT01673087

Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures

Last checked: Nov 19, 2026Latest source record: Apr 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

256

Actual

Start

Oct 2012

Primary completion

Aug 15, 2017

Study completion Aug 15, 2017

Sponsor

Lead sponsor
University of MichiganAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 27, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Cortisol is a stress hormone that can be measured in saliva. This has provided a convenient way to evaluate the biological impact of day-to-day stressors that people encounter as they go about their lives, since saliva is so easy to collect. However, the biological meaning of saliva cortisol measures has never been carefully examined. The goal of this study is to collect saliva from a large group of people as they go about their every-day lives, to measure their cortisol levels, and then study them in the laboratory where Investigators can learn more about how their stress response system (which produces cortisol) is really functioning. Investigators can then determine much more precisely what saliva cortisol levels really mean in terms of stress system biology. This will allow investigators to obtain much more useful information from the next decade of research on naturalistic stress and its biological impact using saliva cortisol measures, helping investigators to understand how stress undermines health and how to combat this effect.

Conditions

  • Stress

Interventions

  • MetyraponeDrug

    750 mcg, oral, administered twice, 3.5 hours apart

  • DexamethasoneDrug

    Administered twice: 1.5 mg, oral, at 11 pm And 0.25 mg, oral, at bedtime at least one week before or after other administration.

  • CortrosynDrug

    250 mcg, IV, bolus, in the afternoon.

  • Corticorelin ovine triflutateDrug

    100 mcg, IV, over 30 seconds, in the afternoon.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. cortisol levelsTime frame: Primarily measuring change from pre-drug baseline to peak occuring about 20 minutes to an hour later

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Michigan Health System

    Ann Arbor, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.